14-day quadruple therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure

被引：0
|
作者：
Thong-Ngam, D [1 ]
Mahachai, V [1 ]
机构：
[1] Chulalongkorn Univ Hosp, Bangkok, Thailand
来源：
HELICOBACTER | 2005年 / 10卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：537 / 538
页数：2
相关论文
共 50 条
  • [31] RANITIDINE-BISMUTH CITRATE AND CLARITROMYCIN DOUBLE THERAPY AS ALTERNATIVE STRATEGY FOR HELICOBACTER PYLORI TREATMENT
    Uyanikoglu, Ahmet
    Davutoglu, Can
    Togan, Mustafa
    Gultepe, Ilhami
    JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2008, 71 (03): : 61 - 64
  • [32] Efficacy of a 14-day quadruple-therapy regimen for third-line Helicobacter pylori eradication
    Huang, Hsiang Tso
    Wang, Hsin-Ming
    Yang, Shih-Cheng
    Tai, Wei-Chen
    Liang, Chih-Ming
    Wu, Keng-Liang
    Lee, Chen-Hsiang
    Chuah, Seng-Kee
    INFECTION AND DRUG RESISTANCE, 2018, 11 : 2073 - 2080
  • [33] A New Pilot Quadruple Therapy for Helicobacter pylori Treatment Failure using Lansoprazole, Bismuth Potassium Citrate, Levofloxacin, and Furazolidone
    Zhang, Zhiqiang
    Xia, Yu
    Yao, Ping
    Yang, Tao
    Li, Xiujuan
    LATIN AMERICAN JOURNAL OF PHARMACY, 2015, 34 (01): : 196 - 200
  • [34] Characteristics of Helicobacter pylori motility and survival in the presence of ranitidine bismuth citrate, bismuth citrate and ranitidine hydrochloride
    Worku, M
    Karim, QN
    GASTROENTEROLOGY, 1997, 112 (04) : A1120 - A1120
  • [35] Fourteen-day hybrid therapy achieves an excellent eradication rate as 14-day bismuth containing quadruple therapy for Helicobacter pylori infection: A randomized controlled trial
    Sun, W. C.
    Tsay, F. W.
    Yu, H. C.
    Wu, D. C.
    Hsu, P. I.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 9 - 9
  • [36] Effectiveness of a ranitidine bismuth citrate triple therapy for treating Helicobacter pylori.
    Smoot, DT
    Hinds, T
    Ashktorab, H
    Jagtap, J
    Kim, KS
    GASTROENTEROLOGY, 1998, 114 (04) : A290 - A290
  • [37] Effectiveness of ranitidine bismuth citrate, clarithromycin, and metronidazole therapy for treating Helicobacter pylori
    Smoot, DT
    Hinds, T
    Ashktorab, H
    Jagtap, J
    Kim, KS
    Scott, VF
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (04): : 955 - 958
  • [38] Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate-based therapies
    Chan, FKL
    Sung, JJY
    Suen, R
    Wu, JCY
    Ling, TKW
    Chung, SCS
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (01) : 91 - 95
  • [39] Efficacy of 7-day bismuth-based quadruple therapy versus 14-day moxifloxacin-based triple therapy for second-line treatment of Helicobacter pylori infection
    Kim, Sung Eun
    Roh, Ji Hun
    Park, Moo In
    Park, Seun Ja
    Moon, Won
    Kim, Jae Hyun
    Jung, Kyoungwon
    Seo, Kwang Il
    Lee, Young Dal
    Seol, Sang Young
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 63 - 63
  • [40] EFFICACY OF 7-DAY BISMUTH-BASED QUADRUPLE THERAPY VERSUS 14-DAY MOXIFLOXACIN-BASED TRIPLE THERAPY FOR SECOND-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION
    Kim, Sung Eun
    Roh, Ji Hun
    Park, Moo In
    Park, Seun Ja
    Moon, Won
    Kim, Jae Hyun
    Jung, Kyoungwon
    Jeong, Joonho
    GASTROENTEROLOGY, 2017, 152 (05) : S248 - S248
12345